Pancreatic ductal adenocarcinoma (PDAC) · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	surveillance
Linked regimen	`None`

ID	`IND-FAMMM-SUSPICION-PREVENTION-ENHANCED-SURVEILLANCE`
Type	Indication
Status	reviewed 2026-05-18 \| pending_clinical_signoff
Diseases	`DIS-PDAC`
Sources	`SRC-NCCN-BCELL-2025`

Notes

STUB — alternative-track for FAMMM. §15.2 C4 ≥2-tracks invariant.

Used By

Algorithms

ALGO-HEREDITARY-MELANOMA-SURVEILLANCE - ALGO-HEREDITARY-MELANOMA-SURVEILLANCE
ALGO-NCCN-PANCREATIC-CAPS-SURVEILLANCE - ALGO-NCCN-PANCREATIC-CAPS-SURVEILLANCE